Dehydroepiandrosterone (DHEA) is a ubiquitous adrenal hormone with immunomodulatory effects such as inhibition of the production of monokines. Whether DHEA itself or the downstream steroids are the immunomodulatory effector hormones in target cells is not known. In this study, we investigated the conversion of DHEA to downstream steroid hormones in target macrophages.
Introduction
A large number of clinical and experimental studies now provide clear evidence that a low serum concentration of the adrenal steroid hormone, dehydroepiandrosterone (DHEA), is associated with a number of inflammatory diseases such as rheumatoid arthritis (Sambrook et al. 1988 , Deighton et al. 1992 , systemic lupus erythematosus (SLE) (Lahita et al. 1987 , Straub et al. 1996 , progressive systemic sclerosis (Straub et al. 1997) , inflammatory bowel disease (Straub et al. 1998b) , and pemphigus (de la Torre et al. 1995) . In inflammatory diseases, low serum DHEA was correlated with a higher disease activity (Lahita et al. 1987 , Deighton et al. 1992 , Straub et al. 1997 . Furthermore, low serum levels of DHEA were linked to diseases without obvious systemic inflammation such as coronary heart disease and atherosclerosis (reviewed in Alexandersen et al. 1996 ), Alzheimer's disease and dementia (Yanase et al. 1996) .
DHEA supplementation had beneficial effects in human SLE (van Vollenhoven et al. 1998 ) and murine models of SLE (Lucas et al. 1985) , in atherosclerosis models in rabbits (Gordon et al. 1988) , virus or parasite infection in rodents (Rasmussen et al. 1995 , Loria et al. 1988 , mouse tuberculosis (Hernandez-Pando et al. 1998) , and in an animal model of type 2 diabetes with elevated serum tumor necrosis factor (TNF) (Kimura et al. 1998) . The common reason for the positive effects of DHEA in the mentioned chronic diseases is probably inhibition of NF-B (Yamada et al. 1994 , Spencer et al. 1997 . In recent years, evidence accumulated shows that DHEA inhibits production of monokines such as interleukin (IL)-6 and TNF from different cell types (Danenberg et al. 1992 , Daynes et al. 1993 , Di Santo et al. 1996 , Kimura et al. 1998 , Padgett & Loria 1998 , Straub et al. 1998a . However, even though some studies demonstrated binding of DHEA to proteins in the cytosol which may be due to a receptor (Yamada et al. 1994 , Meikle et al. 1992 , Okabe et al. 1995 , McLachlan et al. 1996 , a specific receptor for DHEA has not yet been cloned. Downstream derivatives of DHEA such as 3 ,17 -androstenediol (A'diol; Padgett et al. 1997 , Carr 1998 , 4-steroids (androstenedione, A'dione) and estrogens (Ralston et al. 1990 , Pottratz et al. 1994 , Ray et al. 1994 , Shanker et al. 1994 , Kassem et al. 1996 , Deshpande et al. 1997 , Sukovich et al. 1998 ) play a role in immunomodulation. However, conversion of DHEA to downstream hormones in target immune cells has not yet been studied.
Thus, we aimed to investigate whether DHEA is converted to active effector hormones in target cells. Since macrophages play a key role in innate and adaptive immunity in the mentioned chronic inflammatory diseases, the DHEA conversion to downstream hormones needed to be studied in these particular target cells. Furthermore, we addressed the modulation of one of the key enzymes, the aromatase, by DHEA itself and by the typical macrophage activator, lipopolysaccharide (LPS). The knowledge of DHEA conversion to downstream effector hormones and the regulation of key enzymes in macrophages may help to understand some effects of DHEA therapy in chronic inflammatory diseases or arteriosclerosis.
Materials and Methods

Cell culture
Blood was drawn i.v. from healthy subjects who were informed about the purpose of the study and gave written consent. The study was approved by the Ethical Committee of the University of Regensburg. As previously described (Kreutz & Andreesen 1990) , monocytes were isolated from peripheral blood mononuclear cells by countercurrent elutriation ( J6 M-E centrifuge, Beckman, Munich, Germany) using a large volume chamber (50 ml), a JE-5 rotor at 2500 r.p.m., and a flow rate of 110 ml/min in Hank's balanced salt solution supplemented with human plasma. Elutriated monocytes were more than 90% pure, as determined by morphology and antigenic phenotyping. To obtain human monocytederived macrophages, purified monocytes were cultured on hydrophobic Teflon foils (Biofolie 25, Heraeus, Hanau, Germany) at a cell density of 10 6 cells/ml in RPMI 1640 supplemented with 5% pooled human AB-group serum for 8 days (Kreutz & Andreesen 1990) . The cells were then harvested, washed, and suspended in fresh serum-free medium and finally placed in culture plates as indicated below. The serum-free medium (Schmidt & Löffler 1994) consisted of Dulbecco's modified Eagle's medium and Ham's F12 medium at a ratio of 3:1 (both without Phenol Red; Biochrom, Berlin, Germany) supplemented with 100 U/ml penicillin (Biochrom), 100 µg/ml streptomycin (Biochrom), 2 µg/ml transferrin, 17 µ pantothenate, 1 µ biotin, and 1 n insulin (all from Sigma, Deisenhofen, Germany). During culture, cells were kept in a humidified atmosphere with 5% CO 2 at a temperature of 37 C.
Incubation with radiolabeled DHEA and extraction
For analysis of downstream hormones resulting from DHEA conversion, monocyte-derived macrophages were cultivated in serum-free conditions. Macrophages at a density of 2·5 10 6 cells/35 mm dish were incubated in 2 ml serum-free medium for 24 h. Then, 40 nCi [4- 14 C]DHEA (NEN, Dreieich, Germany) were added, which was equivalent to a concentration of 360 nM DHEA. After 1 or 5 days, the culture supernatants were transferred to glass tubes and supplemented with various unlabeled carrier steroids (50 µg each): DHEA, A'dione, A'diol, 3 ,16 ,17 -androstenetriol (A'triol), testosterone, 16-OH-testosterone (16OH-T), estrone, estradiol, estriol (all unlabeled hormones from Sigma). Steroids were extracted twice with 4 ml cold ethyl acetate. More than 99% of the total radioactivity was routinely recovered in the organic phase, which was lyophilized in a speed-vac concentrator.
Thin layer chromatography (TLC) analysis
Lyophilized extracts were dissolved in 50 µl ethanol. Samples of 10 µl were spotted on silica gel 60 F254 TLC aluminium sheets (Merck, Darmstadt, Germany) and developed in two dimensions (Mattox et al. 1979) . The first separation was done in toluene:methanol (90:10). After drying, the second development was done in chloroform:diethylether (50:50). UV illumination allowed identification of the positions of the unlabeled steroid markers for the assessment of the quality of the separation, whereas for identification of DHEA metabolites autoradiography was used. Exposing films for 8-22 days allowed for identification of spots containing less than 0·05% of the total radioactivity. Thereafter, all spots were excised, extracted and added to liquid scintillation cocktail and radioactivity was counted (Ultima Gold, Packard, Frankfurt, Germany). Several additional pieces of each TLC sheet were treated as controls, but these never contained measurable radioactivity. TLC spots were assigned to steroid hormones by co-migration with authentic standards in the two solvent systems and visualized by heating to 130 C after dipping plates into 3% copper(II)-acetate in 8% phosphoric acid (Touchstone 1986 ). This method was validated by assessment of the composition of the major spots (DHEA, 16OH-DHEA, A'diol) by HPLC analysis of extracted spots from parallel TLC sheets (see below). The position of A'diol was additionally verified by demonstrating the co-migration of [1,2- 3 H]androstenediol (NEN) with the respective [4-14 C]DHEA metabolite.
HPLC analysis
The steroids with low R f values in both solvent systems used for TLC were further analyzed by HPLC on a 4 250 mm C2/C18 reverse phase column (5 µm particle size; Pharmacia, Freiburg, Germany). Using water:methanol:acetonitrile (70:20:10) as the solvent system and a flow rate of 1 ml/min at 30 C, A'triol, 16OH-T and estriol could be completely resolved under isocratic conditions (Fig. 2) . Some degradation products (less than 1% of radioactivity) were eluted by a gradient to 30% acetonitrile starting 18 min after injection. Partial degradation of TLC-separated steroids occurred during autoradiography within a few days. Hence, we used TLC sheets exposed for only 3 days, which was sufficient to identify a particular indicator spot ( Fig. 1 , spot 6). This spot was used to define the area of interest on the TLC sheet which was extracted for HPLC analysis (Fig. 1, spot  6 ). Steroids from the small area of interest on the TLC sheet were extracted twice with 700 µl methanol, the combined organic phases were lyophilized, dissolved in methanol, and spiked with unlabeled steroids for UV detection (total volume 50 µl). Samples of 20 µl were fractionated as described above. All fractions were lyophilized, subsequently dissolved in 100 µl methanol, transferred into liquid scintillation cocktail and counted. The purity of the major spots (DHEA, 16OH-DHEA, A'diol) separated by TLC was determined using the same column as described above and a linear gradient of acetonitrile (t=0 min: 24%; t=2 min: 24%; t=13 min: 46%) in water at a flow rate of 1 ml/min at 30 C. Under these conditions the retention times were 6·1 min for 16OH-DHEA, 10·2 min for A'diol and 11·4 min for DHEA, respectively. Spots were extracted and fractions were treated as described above. Radioactivity from extracted spots was found almost exclusively in the corresponding peak upon HPLC analysis (>98% for DHEA, 86% for 16OH-DHEA, and >97% for A'diol), indicating that counting of radioactivity recovered from individual spots is sufficient for quantification.
RT-PCR analysis of the aromatase mRNA
After the indicated time points of cultivation on teflon foils with 5% pooled human AB group serum, cells were transferred to medium containing newborn calf serum for 24 h (Sigma): 2·5 10 6 cells were seeded in 35 mm dishes and incubated with 2 ml medium. RNA was isolated via RNeasy affinity columns (Qiagen, Hilden, Germany). For RT-PCR, 1 µg total RNA was reverse transcribed (1 h at 37 C) using 200 U M-MLV reverse transcriptase (Amersham, Braunschweig, Germany) and subsequently amplified with 2·5 U Taq DNA-polymerase (Boehringer, Mannheim, Germany) for 26 cycles (1 min at 94 C, 1 min at 64 C, 30 s at 74 C) using the oligonucleotides 5 -TTATGAGGAGCATGCGGTACC (forward) and 5 -TAGTGTTCCAGACACCTGTC (reverse) in the presence of 1·5 m MgCl 2 . This protocol leads to amplification of a single 432 bp cDNA-fragment covering parts of exons 9 and 10 of the aromatase gene as shown previously (Schmidt et al. 1998) . For routine analysis, 10 µl of the reaction mixture were dot-blotted according to standard protocols (Sambrook et al. 1989) . Then, the PCR-products were hybridized with 100 ng of a digoxigenin-labeled probe corresponding to the amplified fragment and detected using the DIG luminescence detection system (Boehringer Mannheim, Mannheim, Germany).
Induction of aromatase and assay of aromatase activity
Twenty-four hours after seeding the macrophages in 24-well plates, the medium was replaced by 500 µl of fresh medium with vehicles or with test substances. Substances used were 1 µM DHEA (Sigma) or 1 ng/ml LPS (Salmonella typhimurium, Sigma) or both and the total time of treatment was 24 h. [1 ,2 -3 H]Testosterone (38 nM, 1 µCi/well; NEN) was added as a substrate for the aromatase enzyme 6 h before the incubation was terminated. Aromatase activity was measured by a [ 3 H]-H 2 O release assay as previously described (Schmidt & Löffler 1997) . Aromatase activity is expressed as fmol testosterone per (6 h 10 6 cells).
Statistical analysis
Student's t-test was used to compare the molar amounts of steroids converted between day 1 and day 5. KruskalWallis ANOVA with the Student-Newman-Keul's option was used to test the modulation of aromatase activity by LPS and DHEA (SigmaStat, Jandel, Erkrath, Germany). P<0·05 was the significance level.
Results
Conversion of DHEA to downstream hormones in macrophages
To determine the extent of steroid interconversion in human macrophages, monocyte-derived macrophages were used as a model system. Radiolabeled DHEA (360 nM as the initial concentration) was used as a substrate for the steroid converting enzymes. Under these conditions, 14 detectable radiolabeled steroids accumulated in the culture supernatants of macrophages, as determined by two-dimensional TLC and subsequent autoradiography (Fig. 1) . After 24 h, two major products were identified as A'diol and 16OH-DHEA (Fig. 1A) . Therefore, monocyte-derived macrophages contain high levels of reductive 17 -hydroxysteroid dehydrogenase (17 -HSD) activity and of 16 -hydroxylase activity. Lower amounts of A'dione, testosterone, A'triol, 16OH-T, and estriol were identified, while virtually no estrone or 17 -estradiol were detected after 24 h (Fig. 1A) . Six of the steroids found in very low amounts have not yet been identified (numbered 1-6 in Fig. 1A ). Extended incubations for 5 days led to accumulation of higher amounts of 16OH-DHEA, A'diol and several additional steroids (Fig. 1B) . Parallel incubation of cell-free medium with DHEA for 5 days did not result in any conversion of DHEA (not shown). Steroids, which were poorly resolved by TLC due to their low R f values in both dimensions (Fig. 1B , dotted area), were subsequently analyzed by HPLC. An isocratic reversed phase method led to separation of the 16-hydroxylated steroids (Fig. 2) . The conversion of DHEA to identified steroid hormones is summarized in Figs 3-5. Approximately 1·3% was converted to androgens and about 0·3% was converted to estrogens in addition to 21% 16OH-DHEA and 16% A'diol within 1 day. This is a physiologically relevant amount of androgens and estrogens due to the high affinity for their specific receptors. Particularly, A'triol (Fig. 3) , 16OH-T (Fig. 4) , and estriol (Fig. 5) increased during the 5 day observation period. DHEA and A'dione decreased (Figs 3 and 4) . From these data, it is obvious that macrophages have the capacity to synthesize physiologically relevant amounts of androgens and estrogens from DHEA. The unidentified hormones (spots 1-6 in Fig. 1 ) increased significantly during 5 days of incubation (total amount: 15·1 4·8 to 39·9 4·5 nM, P<0·01).
Aromatase expression in monocytes and macrophages
To further elucidate estrogen biosynthesis in target cells, we studied the time course of aromatase mRNA expression in monocytes and monocyte-derived macrophages. Low amounts of aromatase mRNA were detected by RT-PCR during the early phase of maturation (Fig. 6) . In contrast, strong aromatase mRNA expression was found in 6-8 day maturated cells (Fig. 6) . The culture conditions with or without serum during the 24 h aromatase activity assay yielded similar results (data not shown).
Modulation of aromatase activity by DHEA and LPS in macrophages
Since aromatase is one of the key enzymes for the downstream conversion of DHEA via 4-steroids to estrogens, the modulation of the aromatase activity by DHEA and the typical macrophage activator, LPS, Figure 1 Thin layer chromatography (TLC) separation of products from DHEA conversion in monocyte-derived macrophages. Human macrophages were obtained as described in Materials and Methods. Cells (2·5 10 6 ) were seeded in 35 mm dishes in 2 ml serum-free medium and incubated with 360 nM (40 nCi) [4- 14 C]DHEA for either 1 (A) or 5 days (B). Steroids were extracted as described and aliquots of each sample separated in two dimensions by TLC on silica plates: 1) toluene:methanol (90:10) (arrow 1 in A), 2) chloroform:diethylether (50:50) (arrow 2 in A). Thereafter, the plates were exposed to X-ray film for 8-22 days. The TLC from one representative experiment (out of three) is shown. In A, the positions of all assigned spots are indicated, in B, the positions of only a few spots of interest are indicated (A, androstenedione; T, testosterone; E1, estrone; E2, 17 -estradiol; E3, estriol). S indicates the point of the sample application. Spot 6 indicates the well resolved and easily detectable indicator spot, which was used to identify the area of slowly migrating steroids (B, dotted box). Steroids in this area were extracted for subsequent HPLC analysis.
were investigated. DHEA (1 µ) significantly inhibited aromatase activity (Fig. 7) . In the presence of LPS, DHEA was unable to inhibit aromatase activity (Fig. 7) . Taken together, these results indicate that LPS counteracts the inhibitory action of DHEA on aromatase under these conditions.
Figure 2 HPLC-separation of 16-hydroxylated steroids. Steroids, which migrated slowly in both dimensions during TLC, were extracted and separated under isocratic conditions on a reversed phase column as described in Materials and Methods. A representative chromatogram is shown, where products obtained from a 5 day incubation are separated. Radioactivity was consistently found in the indicated peaks. E3, estriol; U1, U2, U3, unidentified peaks of radioactivity. Peak U1 could be assigned to a degradation product of A'triol (by storage of TLC plates). Peak U3 must be attributed to TLC spot 6, because its activity was nearly identical to that of spots extracted from parallel TLC sheets. 
Discussion
This study demonstrated DHEA conversion to downstream steroid hormones in macrophages. Interconversion of DHEA leads to physiologically relevant amounts of 5-steroids, 4-steroids and estrogens. The 3 -HSD was the rate-limiting enzyme for generation of 4-steroids and estrogens from DHEA because its substrates accumulate, whereas its products, the androgens, and the products of androgen aromatization, the estrogens, are synthesized at significantly lower molar amounts. However, the aromatase is the rate-limiting enzyme under conditions with androgen excess in the aromatase assay (testosterone as a substrate).
DHEA is widely used as a free drug and is currently under investigation as a therapy for systemic lupus erythematosus (van Vollenhoven et al. 1998 ) and other chronic inflammatory diseases. Orally administered DHEA is rapidly resorbed (van Vollenhoven et al. 1994) and, subsequently, the serum concentration of DHEA increases significantly (van Vollenhoven et al. 1994) . DHEA has multiple immunomodulatory effects such as inhibition of monokines (Danenberg et al. 1992 , Daynes et al. 1993 , Di Santo et al. 1996 , Straub et al. 1998a , Padgett & Loria 1998 , Kimura et al. 1998 . DHEA induces peroxisomes in hepatocytes (Leighton et al. 1987 , Sakuma et al. 1993 . Induction of peroxisomes by DHEA and other stimuli inhibited NF-B (Spencer et al. 1997) . Thus, immunosuppressive effects of DHEA are to be expected. However, a specific DHEA receptor, particularly in target monocytes or macrophages, has not yet been identified, although intracellular high-affinity binding sites have been described (Meikle et al. 1992 , Yamada et al. 1994 , Okabe et al. 1995 , McLachlan et al. 1996 . Since downstream hormones of DHEA may be the relevant immunomodulatory effector hormones, we wanted to identify possible metabolic pathways of DHEA conversion to downstream steroid hormones in these target cells. The conversion of DHEA to 5-steroids, 4-steroids and estrogens yielded physiologically relevant molar amounts of the downstream hormones. The main products, after 1 day, were 16OH-DHEA and A'diol. In another study, the latter was shown to be more protective compared with DHEA in an HSV-1 virus infection model (Carr 1998) . This indicates that some effects of DHEA may be due to conversion of DHEA to A'diol in the target tissue, probably also in T lymphocytes. The 5 day incubation of 
Figure 6
Aromatase mRNA expression during macrophage maturation. Cells were isolated and grown on Teflon foil with 5% pooled human AB group serum as described in Materials and Methods. At the indicated time points, cells were transferred to medium containing 5% newborn calf serum (NCS) and seeded in plastic dishes. After 1 day, total RNA was isolated, RT-PCR was performed, and the amplified product was visualized as described. The upper panel shows one representative blot (dots correspond to the respective bars in the lower panel). The results obtained from repeated PCR experiments by videodensitometry are summarized in the lower panel (mean S.E.M.). In the presence or absence of serum, the means of the subgroups at day 1 and 3 significantly differed from the means of the subgroups at day 6 and 8 (P=0·005).
monocyte-derived macrophages led to an increase of A'triol, 16OH-T, and estriol. One study demonstrated that metabolic products of DHEA, such as A'diol and A'triol, had different effects on monokine production of murine macrophages (Padgett et al. 1997) . In this study, DHEA inhibited TNF, IL-6 and IL-1, whereas A'diol was without effect and A'triol increased TNF and IL-1 (Padgett et al. 1997) . This indicates that downstream hormones of DHEA have different effects. Thus, DHEA will probably also have different effects which depend on the kinetics of DHEA conversion to downstream hormones in target cells. Another study demonstrated conversion of A'dione to testosterone and 5 -dihydrotestosterone in human alveolar macrophages (Milewich et al. 1983) . Since DHEA was converted to A'dione in macrophages, these pathways may also be important if DHEA is given therapeutically.
In recent studies, 17 -estradiol was found to inhibit TNF production (Ralston et al. 1990 , Shanker et al. 1994 , Deshpande et al. 1997 ) and IL-6 production (Pottratz et al. 1994 , Ray et al. 1994 , Kassem et al. 1996 , Sukovich et al. 1998 . This indicates that the inhibiting effects of DHEA on production of these monokines (Danenberg et al. 1992 , Daynes et al. 1993 , Di Santo et al. 1996 , Kimura et al. 1998 , Padgett & Loria 1998 , Straub et al. 1998a ) may be mediated via 17 -estradiol. In our study, monocytederived macrophages particularly produced estriol and only small but physiologically relevant amounts of 17 -estradiol from DHEA. In T lymphocytes, estriol was shown to inhibit TNF at low concentrations and stimulate TNF at high concentrations (Correale et al. 1998) . High pharmacological doses of estriol administration resulted in an increase of TNF and IL-6 in mice in vivo (Zuckerman et al. 1996) . Thus, the modulation of monokines by DHEA may be different from expected 17 -estradiol effects. It is of interest that monocytes were not able to synthesize significant amounts of estrogens because the activity of the aromatase was initially very low. After maturation of monocytes to macrophages, the cells were able to convert androgens to estrogens, which confirms an earlier study in the myeloid tumor cell line THP 1 ( Jakob et al. 1995) . Furthermore, we were able to demonstrate that aromatase activity is inhibited by DHEA itself, which was not demonstrated in the presence of the typical macrophage activator LPS. This indicates a complex fine-tuning of local estrogen production by DHEA and LPS in macrophages. It also indicates that there must be similar complex control mechanisms of local cytokine production by DHEA and its derivatives. Thus, inhibition of monokines by therapeutic DHEA depends on the kinetics of the conversion of DHEA to downstream hormones, the state of maturation of monocytes/ macrophages, the concentration of DHEA and LPS at the local site, and the activity of other enzyme systems such as the DHEA sulfatase due to local conditions (Hennebold & Daynes 1994) . From this point of view, multiple consequences of therapeutically administered DHEA on monokine production may emerge. Further studies in macrophages have to address the regulation of the various converting enzymes by the steroid hormones themselves and inflammatory stimuli such as LPS and local cytokines.
